• Patients with available baseline measurements of weight included in the analysis
  • Weight at baseline analyzed as a continuous variable and patients divided into 3 main groups based on drug dosing criteria (dose reduction ≤60 kg) and ISTH recommendations (no NOAC >120 kg):
    • Low weight (≤60 kg)
    • Mid-range weight (>60 to 120 kg)
    • High weight (>120 kg)
  • High-weight patient group further subdivided for additional sensitivity analysis:
    • 121 to 140 kg
    • >140 kg